What specific questions should a respiratory therapist ask during the night-to-day handoff for pediatric cystic fibrosis patients?

Night Shift Handoff Questions for Pediatric Cystic Fibrosis Patients

As a respiratory therapist receiving report on pediatric CF patients, you must systematically assess overnight respiratory status, airway clearance adherence, infection control concerns, and any acute complications—particularly hemoptysis or respiratory distress.

Critical Overnight Events

Respiratory Status Changes

• Did the patient experience any hemoptysis overnight? If yes, quantify the amount: scant (<5 ml), mild-to-moderate (5-240 ml), or massive (>240 ml), as this determines urgency of provider notification 1
• Any new or worsening respiratory symptoms? Specifically ask about increased work of breathing, oxygen requirement changes, or desaturations
• Were there any signs of pneumothorax? New chest pain, sudden respiratory distress, or subcutaneous emphysema 1

Airway Clearance Therapy Compliance

• Was airway clearance therapy completed overnight? CF patients require consistent airway clearance as a fundamental component of lung health maintenance 2, 3
• Which specific technique was used? (CPT, PEP therapy, high-frequency chest wall oscillation, active cycle of breathing) 4
• What was the quality and quantity of secretions produced? Color, consistency, and volume changes may indicate infection or disease progression
• Did the patient tolerate the therapy without difficulty? Any bronchospasm, increased coughing, or distress during treatment

Medication Administration

Inhaled Therapies

• Were all scheduled inhaled medications administered? Specifically:
  • Bronchodilators (especially important if patient demonstrates bronchial hyperreactivity) 2
  • Inhaled antibiotics (e.g., aerosolized tobramycin for chronic suppression)
  • Mucolytics (dornase alfa)
  • Hypertonic saline
• What was the sequence of medication administration? Bronchodilators should precede airway clearance and other inhaled therapies
• Did the patient demonstrate any bronchodilator responsiveness or adverse reactions? 2

Infection Control and Microbiology

Pathogen Status

• What is the patient's current sputum culture status? Specifically ask about:
  • Pseudomonas aeruginosa colonization
  • Burkholderia cepacia complex
  • MRSA
  • Other multiresistant organisms 5
• Were infection control precautions maintained? This affects morning care planning and room assignment 5
• Any new fever or signs of pulmonary exacerbation overnight?

Oxygen and Ventilatory Support

• What were the overnight oxygen requirements? Baseline flow rate, any increases needed, and SpO2 trends
• If on non-invasive ventilation, what were the settings and tolerance?
• Were there any apneic episodes or significant desaturations?

Age-Specific Considerations

For Infants and Young Children (<6 years)

• Was modified 5-position CPT completed? This is the primary airway clearance method for this age group 4
• Did caregivers participate in overnight therapy? Parental involvement is crucial for adherence 4
• Any feeding difficulties or aspiration concerns? These can complicate respiratory status

For School-Age Children (6-12 years)

• Which independent airway clearance technique did they use? (PEP therapy typically introduced around 6-7 years) 4
• Did they require supervision or complete therapy independently?

For Adolescents

• Did they complete therapy without prompting? Adherence issues are common in this age group
• Any psychosocial concerns affecting treatment compliance?

Common Pitfalls to Avoid

• Don't assume stable patients had uneventful nights—CF lung disease can deteriorate rapidly, and early intervention prevents complications 2
• Don't overlook small amounts of hemoptysis—even mild hemoptysis (>5 ml) requires provider notification 1
• Don't accept vague answers about airway clearance—you need specifics about technique, duration, and secretion production to assess effectiveness 3
• Don't forget to ask about antibiotic resistance patterns—patients may still benefit from inhaled antibiotics despite in vitro resistance 2

Documentation Verification

• Review overnight vital signs trends, not just single values
• Confirm all respiratory treatments are documented with patient response
• Verify any PRN treatments given and the indication

This systematic approach ensures you capture the critical overnight information needed to provide safe, effective respiratory care and maintain the chronic medication regimens essential for preserving lung function in pediatric CF patients 2, 3.